IMPACT OF POOR PERSISTENCE AND ADHERENCE
Despite the development of great therapeutic interventions many patients still do not thrive or achieve optimal results on their treatment. The reason for these poor patient outcomes can vary from lack of education about the disease or treatment to the inability to afford medicine, or lack of adherence to their therapy. According to the WHO only 50% of the patients with chronic conditions take their medication as prescribed, For Pharmaceutical companies this translates roughly into ONE RAND in lost revenue for every SALES rand realized.
+ PHARMACALL =
By bridging the gap “beyond the prescription” we are able to ensure that all role players benefit, from the Patient to the Doctor to Funder and Manufacturer
EXPERIENCE, KNOWLEDGE and TECHNOLOGY
SUCCESS BEYOND the PRESCRIPTION